Orbimed Advisors LLC Inozyme Pharma, Inc. Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.87 - $7.55 $2.04 Million - $3.98 Million	-526,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.58 - $11.5 $1.3 Million - $2.67 Million	232,600 Added 79.12%	526,600 $3.59 Million
Q3 2021 Nov 15, 2021	BUY	$11.12 - $19.4 $1.17 Million - $2.04 Million	105,296 Added 55.8%	294,000 $3.41 Million
Q2 2021 Aug 16, 2021	BUY	$15.19 - $21.2 $2.87 Million - $4 Million	188,704 New	188,704 $3.22 Million
Q1 2021 May 17, 2021	SELL	$17.77 - $27.9 $7.12 Million - $11.2 Million	-400,400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.54 - $30.2 $7.02 Million - $12.1 Million	400,400 New	400,400 $10.5 Million

53.1M

3.7K

5.8K

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $54.6M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.